Skip to main content
OpenTrials
Completed

NCT Number: NCT06248788

Salivary Immunoglobulin A (sIgA) Normal Range Study

Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Salivary Immunity

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

4Life Research

Sandy City, Utah, 84070, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults committed to attend the session and follow the instructions described in Experimental Design will be included.

Exclusion criteria

  • Participant with mouth infection or oral disease

Treatment and study plan

PoC Device

Device

PoC Device for Testing Salivary IgA

Primary outcomes

  1. Salivary IgA

    Time frame: 0 minute

Sponsors and collaborators

Lead sponsor

4Life Research, LLC

Industry

Registry information

Official study title

Study to Survey the Normal Range of Salivary Immunoglobulin A (sIgA) Levels Measured by a Point of Care Device in Healthy Adult Women and Men

Acronym: sIgA

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Feb 8, 2024
Registry last updated
Feb 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.